Active Ingredient(s):Vigabatrin FDA Approved: * June 21, 2018 Pharm Company: *AUCTA PHARMS Category:Anticonvulsant
Vigabatrin, brand name Sabril, is a medication used to treat epilepsy. It became available as a generic medication in 2019.
It works by inhibiting the breakdown of γ-aminobutyric acid (GABA). It is also known as γ-vinyl-GABA, and is a structural analogue of GABA, but does not bind to GABA receptors.
1 Medical uses
2 Adverse effects
2.1 Central nervous system
2.3 Body as a whole
* May have multiple approval dates, manufacturers, or labelers.